ArticleOpen forum infectious diseases2023

Correction to: Population-Level Strategies for Nirmatrelvir/Ritonavir Prescribing-A Cost-effectiveness Analysis.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.